A riveting tale of corruption, deception, and lies in the medical industry. Families were broken, lives lost, and countless suffering was caused. However, with awareness comes hope! A history told from the future, so that we do not repeat the past. Hold onto your seats and get ready to have your mind blown!

During the Cold War, an alliance between American scientists, pharmaceutical companies, and the US military pushed the medical establishment into ethically fraught territory. Doctors and scientists at prestigious institutions were pressured to produce medical advances to compete with the perceived threats coming from the Soviet Union. In Against Their Will, authors Allen Hornblum, Judith Newman, and Gregory Dober reveal the little-known history of unethical and dangerous medical experimentation on children in the United States. Through rare interviews and the personal correspondence of renowned medical investigators, they document how children—both normal and those termed "feebleminded"—from infants to teenagers, became human research subjects in terrifying experiments. They were drafted as "volunteers" to test vaccines, doused with ringworm, subjected to electric shock, and given lobotomies. They were also fed radioactive isotopes and exposed to chemical warfare agents. This groundbreaking book shows how institutional superintendents influenced by eugenics often turned these children over to scientific researchers without a second thought. Based on years of archival work and numerous interviews with both scientific researchers and former test subjects, this is a fascinating and disturbing look at the dark underbelly of American medical history.

The Evolution of Modern Medicine; A Series of Lectures Delivered at Yale University on the Silliman Foundation in April, 1913, is many of the old classic books which have been considered important throughout the human history. They are now extremely scarce and very expensive antique. So that this work is never forgotten we republish these books in high quality, using the original text and artwork so that they can be preserved for the present and future generations. This whole book has been reformatted, retyped and designed. These books are not made of scanned copies of their original work and hence the text is clear and readable.

Journalist and author of the New York Times bestselling Unbroken Brain tackles the revolutionary concept of harm reduction, how it can transform the treatment of addiction, and how it holds the potential to revolutionize our treatment of behavioral and societal issues. In her New York Times bestseller Unbroken Brain, journalist Maia Szalavitz took an unflinching look at addiction, challenging the idea of the "broken brain" to offer a groundbreaking perspective on addiction as a learning disorder. Now she turns her keen eye and narrative powers to the surprisingly simple--and extremely divisive--practice of harm reduction, which is a revolutionary means to solving the drug addiction crisis. Drug overdoses now kill more Americans annually than guns, cars or breast cancer. But in the name of "sending the right message," we have criminalized drug addiction, denied those who are addicted medical care, housing and other benefits, and have deliberately allowed the spread of fatal diseases. Yet there is an alternative to our present system, one that has been proven to work, but which runs counter to the received wisdom of our criminal and medical industrial complexes. It is called harm reduction. A surprisingly simple idea with enormous power, harm reduction takes the focus off of drug use and instead works to minimize associated damage. It represents the philosophy behind needle exchange programs and providing heroin addicts with the overdose medication naloxone instead of arresting them. It is focused not on punishing pleasure but on minimizing harm; in essence, it is a wholesale refutation of the American way of justice. Undoing Drugs tells the story of harm reduction. It will show how this concept has begun to transform the treatment of addiction and how it holds the potential to revolutionize how we deal with a range of other urgent behavioral and societal issues. Harm reduction challenges people to prioritize radical empathy and kindness over punishment as a way of not only dealing with drug use, but also in questions related to racism, sexism, disability and inequality. And, as Szalavitz shows, it says unequivocally that we must be more concerned about saving lives and health than about criminalizing quality-of-life crimes. Szalavitz argues for a practical application of the Hippocratic oath to "First, do no harm" beyond medicine and to those who urgently need it most.

The turbulent history of generic pharmaceuticals raises powerful questions about similarity and difference in modern medicine. Generic drugs are now familiar objects in clinics, drugstores, and households around the world. We like to think of these tablets, capsules, patches, and ointments as interchangeable with their brand-name counterparts: why pay more for the same? And yet they are not quite the same. They differ in price, in place of origin, in color, shape, and size, in the dyes, binders, fillers, and coatings used, and in a host of other ways. Claims of generic equivalence, as physician-historian Jeremy Greene reveals in this gripping narrative, are never based on being identical to the original drug in all respects, but in being the same in all ways that matter. How do we know what parts of a pill really matter? Decisions about which differences are significant and which are trivial in the world of therapeutics are not resolved by simple chemical or biological assays alone. As Greene reveals in this fascinating account, questions of therapeutic similarity and difference are also always questions of pharmacology and physiology, of economics and politics, of morality and belief. Generic is the first book to chronicle the social, political, and cultural history of generic drugs in America. It narrates the evolution of the generic drug industry from a set of mid-twentieth-century "schlock houses" and "counterfeiters" into an agile and surprisingly powerful set of multinational corporations in the early twenty-first century. The substitution of bioequivalent generic drugs for more expensive brand-name products is a rare success story in a field of failed attempts to deliver equivalent value in health care for a lower price. Greene’s history sheds light on the controversies shadowing the success of generics: problems with the generalizability of medical knowledge, the fragile role of science in public policy, and the increasing role of industry, marketing, and consumer logics in late-twentieth-century and early twenty-first century health care.

Makers of Modern Medicine, has been considered an important book throughout the human history. So that this work is never forgotten we have made efforts in its preservation by republishing this book in a modern format for present and future generations. The whole book has been reformatted, retyped and designed. This book is not made of scanned copies and hence the text is clear and readable.

This book is a highly readable and entertaining account of the co-evolution of the patent system and the life science industries since the mid-19th century. The pharmaceutical industries have their origins in advances in synthetic chemistry and in natural products research. Both approaches to drug discovery and business have shaped patent law, as have the lobbying activities of the firms involved and their supporters in the legal profession. In turn, patent law has impacted on the life science industries. Compared to the first edition, which told this story for the first time, the present edition focuses more on specific businesses, products and technologies, including Bayer, Pfizer, GlaxoSmithKline, aspirin, penicillin, monoclonal antibodies and polymerase chain reaction. Another difference is that this second edition also looks into the future, addressing new areas such as systems biology, stem cell research, and synthetic biology, which promises to enable scientists to “invent” life forms from scratch.

Since the early twentieth century, the United States has led a global prohibition effort against certain drugs in which production restriction and criminalization are emphasized over prevention and treatment as means to reduce problematic usage. This “war on drugs” is widely seen to have failed, and periodically decriminalization and legalization movements arise. Debates continue over whether the problems of addiction and crime associated with illicit use of drugs stem from their illegal status or the nature of the drugs themselves. In The Long War on Drugs Anne L. Foster explores the origin of the punitive approach to drugs and its continued appeal despite its obvious flaws. She provides a comprehensive overview, focusing not only on a political history of policy developments but also on changes in medical practices and understanding of drugs. Foster also outlines the social and cultural changes prompting different attitudes about drugs; the racial, environmental, and social justice implications of particular drug policies; and the international consequences of US drug policy.